<?xml version='1.0' encoding='utf-8'?>
<document id="28224698"><sentence text="Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients."><entity charOffset="68-80" id="DDI-PubMed.28224698.s1.e0" text="Voriconazole" /><entity charOffset="81-93" id="DDI-PubMed.28224698.s1.e1" text="Posaconazole" /><pair ddi="false" e1="DDI-PubMed.28224698.s1.e0" e2="DDI-PubMed.28224698.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s1.e0" e2="DDI-PubMed.28224698.s1.e1" /></sentence><sentence text="Administration of azole antifungals to tacrolimus-treated solid organ recipients results in a major drug-drug interaction characterized by increased exposure to tacrolimus"><entity charOffset="18-23" id="DDI-PubMed.28224698.s2.e0" text="azole" /><entity charOffset="39-49" id="DDI-PubMed.28224698.s2.e1" text="tacrolimus" /><entity charOffset="161-171" id="DDI-PubMed.28224698.s2.e2" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.28224698.s2.e0" e2="DDI-PubMed.28224698.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s2.e0" e2="DDI-PubMed.28224698.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s2.e0" e2="DDI-PubMed.28224698.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s2.e1" e2="DDI-PubMed.28224698.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s2.e1" e2="DDI-PubMed.28224698.s2.e2" /></sentence><sentence text=" The magnitude of this interaction is highly variable but cannot currently be predicted" /><sentence text=" We performed a retrospective analysis of 126 solid organ recipients (95 lung, 31 kidney) co-treated with tacrolimus and voriconazole (n = 100) or posaconazole (n = 26)"><entity charOffset="106-116" id="DDI-PubMed.28224698.s4.e0" text="tacrolimus" /><entity charOffset="121-133" id="DDI-PubMed.28224698.s4.e1" text="voriconazole" /><entity charOffset="147-159" id="DDI-PubMed.28224698.s4.e2" text="posaconazole" /><entity charOffset="128-139" id="DDI-PubMed.28224698.s4.e3" text="azole" /><entity charOffset="154-165" id="DDI-PubMed.28224698.s4.e4" text="azole" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e0" e2="DDI-PubMed.28224698.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e0" e2="DDI-PubMed.28224698.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e0" e2="DDI-PubMed.28224698.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e0" e2="DDI-PubMed.28224698.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e0" e2="DDI-PubMed.28224698.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e1" e2="DDI-PubMed.28224698.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e1" e2="DDI-PubMed.28224698.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e1" e2="DDI-PubMed.28224698.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e1" e2="DDI-PubMed.28224698.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e3" e2="DDI-PubMed.28224698.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e3" e2="DDI-PubMed.28224698.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e3" e2="DDI-PubMed.28224698.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e2" e2="DDI-PubMed.28224698.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s4.e2" e2="DDI-PubMed.28224698.s4.e4" /></sentence><sentence text=" Predictors of the change in tacrolimus dose-corrected trough concentrations (C/D) between baseline and tacrolimus-azole co-therapy were assessed using linear mixed modeling"><entity charOffset="29-39" id="DDI-PubMed.28224698.s5.e0" text="tacrolimus" /><entity charOffset="104-120" id="DDI-PubMed.28224698.s5.e1" text="tacrolimus-azole" /><entity charOffset="115-130" id="DDI-PubMed.28224698.s5.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.28224698.s5.e0" e2="DDI-PubMed.28224698.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s5.e0" e2="DDI-PubMed.28224698.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s5.e0" e2="DDI-PubMed.28224698.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28224698.s5.e1" e2="DDI-PubMed.28224698.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28224698.s5.e1" e2="DDI-PubMed.28224698.s5.e2" /></sentence><sentence text=" Patients were genotyped for relevant polymorphisms in CYP3A4, CYP3A5, MDR1, CYP2C19, POR, and UGT1A4" /><sentence text=" Tacrolimus C/D increased by a factor 5" /><sentence text="0 ± 2" /><sentence text="7 (range 1" /><sentence text="0-20" /><sentence text="2) for voriconazole and 4"><entity charOffset="7-19" id="DDI-PubMed.28224698.s11.e0" text="voriconazole" /><entity charOffset="14-25" id="DDI-PubMed.28224698.s11.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.28224698.s11.e0" e2="DDI-PubMed.28224698.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s11.e0" e2="DDI-PubMed.28224698.s11.e1" /></sentence><sentence text="4 ± 2" /><sentence text="6 (range 0" /><sentence text="9-18" /><sentence text="0) for posaconazole, suggesting that a 66% dose reduction is insufficient for the majority of patients"><entity charOffset="7-19" id="DDI-PubMed.28224698.s15.e0" text="posaconazole" /><entity charOffset="14-25" id="DDI-PubMed.28224698.s15.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.28224698.s15.e0" e2="DDI-PubMed.28224698.s15.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s15.e0" e2="DDI-PubMed.28224698.s15.e1" /></sentence><sentence text=" Change in C/D was blunted in CYP3A5 expressors (estimated effect: -43%, p = 0" /><sentence text="017) and affected by hematocrit (+8% per %, p = 0" /><sentence text="004), baseline C/D (-14% per 100% increase, p &lt; 0" /><sentence text="001), and age (+1%, p = 0" /><sentence text="008)" /><sentence text=" However, the final model explained only 22% of interindividual variability in C/D change" /><sentence text=" In conclusion, CYP3A5 genotype and several clinical variables were identified as modulators of the tacrolimus-azole interaction, but these did not permit accurate predictions in individual patients"><entity charOffset="100-116" id="DDI-PubMed.28224698.s22.e0" text="tacrolimus-azole" /><entity charOffset="111-126" id="DDI-PubMed.28224698.s22.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.28224698.s22.e0" e2="DDI-PubMed.28224698.s22.e0" /><pair ddi="false" e1="DDI-PubMed.28224698.s22.e0" e2="DDI-PubMed.28224698.s22.e1" /></sentence><sentence text="" /></document>